Clinical Trials Directory

Trials / Terminated

TerminatedNCT03708029

Efficacy of Human Placental Graft in Diabetic Foot Ulcers

A Clinical Investigation Into the Efficacy of Full-thickness Human Placental Graft (Revita) in Diabetic Foot Ulcers

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
StimLabs · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To determine the efficacy of full-thickness placental allograft in chronic wound healing

Detailed description

To evaluate the efficacy of Revita full thickness placental allograft in improving wound closure rates and mean closure time in diabetic foot ulcers (DFUs) as compared to the current standards of wound care treatment

Conditions

Interventions

TypeNameDescription
OTHERRevita AllograftHuman placental allograft

Timeline

Start date
2018-11-13
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2018-10-16
Last updated
2024-07-01

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03708029. Inclusion in this directory is not an endorsement.

Efficacy of Human Placental Graft in Diabetic Foot Ulcers (NCT03708029) · Clinical Trials Directory